Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Caris Life Sciences Inc (CAI)

Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,383,149
  • Shares Outstanding, K 282,580
  • Annual Sales, $ 812,030 K
  • Annual Income, $ -68,090 K
  • EBIT $ -46 M
  • EBITDA $ 80 M
  • 60-Month Beta N/A
  • Price/Sales 6.32
  • Price/Cash Flow 11.39
  • Price/Book 8.87

Options Overview Details

View History
  • Implied Volatility 113.92% (+33.12%)
  • Historical Volatility 59.43%
  • IV Percentile 99%
  • IV Rank 95.75%
  • IV High 116.59% on 02/19/26
  • IV Low 53.81% on 01/21/26
  • Expected Move (DTE 2) 1.52 (8.21%)
  • Put/Call Vol Ratio 0.18
  • Today's Volume 90
  • Volume Avg (30-Day) 412
  • Put/Call OI Ratio 0.78
  • Today's Open Interest 8,353
  • Open Int (30-Day) 7,655
  • Expected Range 17.02 to 20.06

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate -0.04
  • Number of Estimates 3
  • High Estimate -0.02
  • Low Estimate -0.06
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.15 +8.10%
on 02/24/26
21.61 -14.21%
on 02/18/26
-2.26 (-10.87%)
since 02/17/26
3-Month
17.15 +8.10%
on 02/24/26
29.32 -36.77%
on 01/07/26
-8.65 (-31.81%)
since 12/17/25

Most Recent Stories

More News
Caris Life Sciences Introduces Powerful New Caris AI Insights to Identify Early Platinum Resistance in Ovarian Cancer

Caris AI Insights are proprietary and only available to Caris Life Sciences customers  

CAI : 18.54 (-2.68%)
Caris Life Sciences to Showcase Five Studies at the 2026 USCAP Annual Meeting

IRVING, Texas , March 11, 2026 /PRNewswire/ -- Caris Life Sciences ® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced...

CAI : 18.54 (-2.68%)
Caris Life Sciences Launches a Novel Caris AI Insights Signature to Guide First-Line Therapy Selection and Treatment De-Escalation in Pancreatic Cancer

Caris AI Insights are proprietary and only available to Caris Life Sciences customers

CAI : 18.54 (-2.68%)
Stocks Settle Lower as Bank Shares Tumble and Tech Stocks Fall

The S&P 500 Index ($SPX ) (SPY ) on Friday closed down -0.43%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down -1.05%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.30%. March E-mini...

ALK : 38.95 (+1.33%)
APO : 108.89 (+5.26%)
TRI : 95.52 (-0.63%)
DUOL : 104.36 (+2.36%)
CRWV : 82.12 (-4.36%)
PSKY : 9.23 (-2.84%)
AMD : 196.31 (-0.14%)
SPY : 670.79 (+0.26%)
SYF : 65.15 (+1.77%)
ADSK : 252.92 (+1.26%)
MS : 157.83 (+1.37%)
ORCL : 154.69 (-0.82%)
Stocks Retreat on AI Disruption Concerns and Geopolitical Risks

The S&P 500 Index ($SPX ) (SPY ) today is down -0.61%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -1.17%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.41%. March E-mini S&P futures...

ALK : 38.95 (+1.33%)
APO : 108.89 (+5.26%)
ADI : 313.66 (+0.88%)
TRI : 95.52 (-0.63%)
DUOL : 104.36 (+2.36%)
CRWV : 82.12 (-4.36%)
PSKY : 9.23 (-2.84%)
AMD : 196.31 (-0.14%)
SPY : 670.79 (+0.26%)
ADSK : 252.92 (+1.26%)
ORCL : 154.69 (-0.82%)
CAI : 18.54 (-2.68%)
Stocks Fall on AI Fears and Stronger-Than-Expected Producer Prices

The S&P 500 Index ($SPX ) (SPY ) today is down -0.90%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -1.57%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.71%. March E-mini S&P futures...

APO : 108.89 (+5.26%)
AVGO : 321.31 (-1.11%)
FLUT : 109.25 (+0.53%)
ADI : 313.66 (+0.88%)
DDOG : 128.87 (+1.82%)
RKLB : 78.59 (+10.21%)
TRI : 95.52 (-0.63%)
TXN : 194.45 (+0.16%)
$IUXX : 24,780.42 (+0.51%)
DUOL : 104.36 (+2.36%)
ASML : 1,389.16 (+0.99%)
NATL : 43.93 (-0.30%)
Caris Life Sciences Completes Interim Readout of Achieve 1 Study

Demonstrates Superior Sensitivity and Specificity of Caris Detect

CAI : 18.54 (-2.68%)
Caris Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook

Full year revenue growth of 97% driven by strong performance in molecular profiling services

CAI : 18.54 (-2.68%)
Caris Launches Proprietary AI Insights Signature Which Deepens Understanding of Response to Breast Cancer Patients' Oral Chemotherapy Drug

IRVING, Texas , Feb. 24, 2026 /PRNewswire/ -- Caris Life Sciences ®  (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today...

CAI : 18.54 (-2.68%)
Caris Life Sciences to Participate in the TD Cowen 46th Annual Health Care Conference

IRVING, Texas , Feb. 23, 2026 /PRNewswire/ --  Caris Life Sciences ®  (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced...

CAI : 18.54 (-2.68%)

Business Summary

Caris Life Sciences Inc. provides diagnostics and anatomic pathology services. It develops an unbiased profiling platform for novel target identification, drug development and delivery, diagnostic and disease monitoring and precision medicine enabling aspects. Caris Life Sciences Inc. is based in Irving,...

See More

Key Turning Points

3rd Resistance Point 20.68
2nd Resistance Point 20.16
1st Resistance Point 19.35
Last Price 18.54
1st Support Level 18.02
2nd Support Level 17.51
3rd Support Level 16.70

See More

52-Week High 42.50
Fibonacci 61.8% 32.82
Fibonacci 50% 29.83
Fibonacci 38.2% 26.83
Last Price 18.54
52-Week Low 17.15

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar